Atish D Choudhury (Atish Choudhury)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 34

Top Topics

Radical Prostatectomy

Dna Damage Response

Top Venues

Nature communications

Cancer immunology research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yaping Liu, Sarah C Reed, Christopher Lo, Atish D Choudhury, Heather A Parsons, Daniel G Stover, Gavin Ha, Gregory Gydush, Justin Rhoades, Denisse Rotem, Samuel S Freeman, David W Katz, Ravi Bandaru, Haizi Zheng, Hailu Fu, Viktor A Adalsteinsson, Manolis Kellis
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA. Nature communications 15 (1) (2024)
Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez Garcia, David D Yang, Abhishek Tripathi, Jacqueline M Kilar, Meredith Flynn, Brianna Maynard, Rebecca Reichel, Amanda F Pace, Brandon K Chen, Eliezer Van Allen, Kerry L Kilbridge, Xiao X Wei, Bradley Alexander McGregor, Mark M Pomerantz, Rupal S Bhatt, Christopher J Sweeney, Glenn J Bubley, Heather A Jacene, Mary-Ellen Taplin, Franklin W Huang, Lauren C Harshman, Lawrence Fong
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer. Cancer immunology research 12 (6) (2024)
Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez Garcia, David D Yang, Abhishek Tripathi, Jacqueline M Kilar, Meredith Flynn, Brianna Maynard, Rebecca Reichel, Amanda F Pace, Brandon K Chen, Eliezer Van Allen, Kerry L Kilbridge, Xiao X Wei, Bradley Alexander McGregor, Mark M Pomerantz, Rupal S Bhatt, Christopher J Sweeney, Glenn J Bubley, Heather A Jacene, Mary-Ellen Taplin, Franklin W Huang, Lauren C Harshman, Lawrence Fong
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer. Cancer immunology research (2024)
Yaping Liu, Sarah C Reed, Christopher Lo, Atish D Choudhury, Heather A Parsons, Daniel G Stover, Gavin Ha, Gregory Gydush, Justin Rhoades, Denisse Rotem, Samuel S Freeman, David W Katz, Ravi Bandaru, Haizi Zheng, Hailu Fu, Viktor A Adalsteinsson, Manolis Kellis
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA. Nature communications 15 (1) (2024)
Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez Garcia, David D Yang, Abhishek Tripathi, Jacqueline M Kilar, Meredith Flynn, Brianna Maynard, Rebecca Reichel, Amanda F Pace, Brandon K Chen, Eliezer Van Allen, Kerry L Kilbridge, Xiao X Wei, Bradley Alexander McGregor, Mark M Pomerantz, Rupal S Bhatt, Christopher J Sweeney, Glenn J Bubley, Heather A Jacene, Mary-Ellen Taplin, Franklin W Huang, Lauren C Harshman, Lawrence Fong
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer. Cancer immunology research 12 (6) (2024)
Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez Garcia, David D Yang, Abhishek Tripathi, Jacqueline M Kilar, Meredith Flynn, Brianna Maynard, Rebecca Reichel, Amanda F Pace, Brandon K Chen, Eliezer Van Allen, Kerry L Kilbridge, Xiao X Wei, Bradley Alexander McGregor, Mark M Pomerantz, Rupal S Bhatt, Christopher J Sweeney, Glenn J Bubley, Heather A Jacene, Mary-Ellen Taplin, Franklin W Huang, Lauren C Harshman, Lawrence Fong
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer. Cancer immunology research (2024)
Yaping Liu, Sarah C Reed, Christopher Lo, Atish D Choudhury, Heather A Parsons, Daniel G Stover, Gavin Ha, Gregory Gydush, Justin Rhoades, Denisse Rotem, Samuel S Freeman, David W Katz, Ravi Bandaru, Haizi Zheng, Hailu Fu, Viktor A Adalsteinsson, Manolis Kellis
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA. Nature communications 15 (1) (2024)
Yaping Liu, Sarah C Reed, Christopher Lo, Atish D Choudhury, Heather A Parsons, Daniel G Stover, Gavin Ha, Gregory Gydush, Justin Rhoades, Denisse Rotem, Samuel S Freeman, David W Katz, Ravi Bandaru, Haizi Zheng, Hailu Fu, Viktor A Adalsteinsson, Manolis Kellis
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA. Nature communications 15 (1) (2024)
Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez Garcia, David D Yang, Abhishek Tripathi, Jacqueline M Kilar, Meredith Flynn, Brianna Maynard, Rebecca Reichel, Amanda F Pace, Brandon K Chen, Eliezer Van Allen, Kerry L Kilbridge, Xiao X Wei, Bradley Alexander McGregor, Mark M Pomerantz, Rupal S Bhatt, Christopher J Sweeney, Glenn J Bubley, Heather A Jacene, Mary-Ellen Taplin, Franklin W Huang, Lauren C Harshman, Lawrence Fong
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer. Cancer immunology research 12 (6) (2024)
Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez Garcia, David D Yang, Abhishek Tripathi, Jacqueline M Kilar, Meredith Flynn, Brianna Maynard, Rebecca Reichel, Amanda F Pace, Brandon K Chen, Eliezer Van Allen, Kerry L Kilbridge, Xiao X Wei, Bradley Alexander McGregor, Mark M Pomerantz, Rupal S Bhatt, Christopher J Sweeney, Glenn J Bubley, Heather A Jacene, Mary-Ellen Taplin, Franklin W Huang, Lauren C Harshman, Lawrence Fong
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer. Cancer immunology research 12 (6) (2024)
Shehzad Basaria, Mary-Ellen Taplin, Marie McDonnell, Donald C Simonson, Alexander P Lin, Alyssa B Dufour, Daniel Habtemariam, Paul L Nguyen, Praful Ravi, Adam S Kibel, Christopher J Sweeney, Anthony V D'Amico, Daniel A Roberts, Wenxin Xu, Xiao X Wei, Rajitha Sunkara, Atish D Choudhury, Charlene Mantia, Himisha Beltran, Mark M Pomerantz, Jacob E Berchuck, Neil E Martin, Jonathan E Leeman, Kent W Mouw, Kerry E Kilbridge, Richelle Bearup, Hannah Kackley, Hussein Kafel, Grace Huang, Kieran F Reid, Thomas Storer, Milena Braga-Basaria, Thomas G Travison
Insulin resistance during androgen deprivation therapy in men with prostate cancer. Cancer (2024)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Stephanie A Berg, Atish D Choudhury
Mutual ATRaction: Assessing synergy of berzosertib with sacituzumab govitecan. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Zachary Quinn, Benjamin E Leiby, Guru P Sonpavde, Atish D Choudhury, Christopher J Sweeney, David J Einstein, Russell Zelig Szmulewitz, A Oliver Sartor, Beatrice Knudsen, Eddy Shih-Hsin Yang, William Kevin Kelly
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Elizabeth H Stover, Coyin Oh, Paula Keskula, Atish D Choudhury, Yuen-Yi Tseng, Viktor A Adalsteinsson, Jens G Lohr, Aaron R Thorner, Matthew Ducar, Gregory V Kryukov, Gavin Ha, Mara Rosenberg, Samuel S Freeman, Zhenwei Zhang, Xiaoyun Wu, Eliezer M Van Allen, David Y Takeda, Massimo Loda, Chin-Lee Wu, Mary-Ellen Taplin, Levi A Garraway, Jesse S Boehm, Franklin W Huang
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples. The Prostate 82 (5) (2022)
Atish D Choudhury
PTEN-PI3K pathway alterations in advanced prostate cancer and clinical implications. The Prostate (2022)
Jacob E Berchuck, Daniel Boiarsky, Rebecca Silver, Rajitha Sunkara, Heather M McClure, Harrison K Tsai, Stephanie E Siegmund, Alok K Tewari, Jonathan Andrew Nowak, Neal I Lindeman, Huma Q Rana, Atish D Choudhury, Mark M Pomerantz, Matthew L Freedman, Eliezer Van Allen, Mary-Ellen Taplin
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer. JCO precision oncology 6 (2022)
Navonil DeSarkar, Robert D Patton, Anna-Lisa Doebley, Brian Hanratty, Mohamed Adil, Adam J Kreitzman, Jay F Sarthy, Minjeong Ko, Sandipan Brahma, Michael P Meers, Derek H Janssens, Lisa S Ang, Ilsa M Coleman, Arnab Bose, Ruth F Dumpit, Jared M Lucas, Talina A Nunez, Holly M Nguyen, Heather M McClure, Colin C Pritchard, Michael Thomas Schweizer, Colm Morrissey, Atish D Choudhury, Sylvan C Baca, Jacob E Berchuck, Matthew L Freedman, Kami Ahmad, Michael C Haffner, Robert B Montgomery, Eva Corey, Steven Henikoff, Peter S Nelson, Gavin Ha
Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes. Cancer discovery (2022)
Gregory Gydush, Erica Nguyen, Jin H Bae, Timothy Blewett, Justin Rhoades, Sarah C Reed, Douglas Shea, Kan Xiong, Ruolin Liu, Fangyan Yu, Ka Wai Leong, Atish D Choudhury, Daniel G Stover, Sara M Tolaney, Ian E Krop, John Christopher Love, Heather A Parsons, G Mike Makrigiorgos, Todd R Golub, Viktor A Adalsteinsson
Massively parallel enrichment of low-frequency alleles enables duplex sequencing at low depth. Nature biomedical engineering 6 (3) (2022)
Kasia M Dillon, Raie T Bekele, Zsofia Sztupinszki, Timothy Hanlon, Shahrzad Rafiei, Zoltan Szallasi, Atish D Choudhury, Kent W Mouw
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer. NPJ precision oncology 6 (1) (2022)
Atish D Choudhury, Celestia S Higano, Johann S de Bono, Natalie Cook, Dana E Rathkopf, Kari B Wisinski, Juan Martin-Liberal, Mark Linch, Elisabeth I Heath, Richard D Baird, Javier García Corbacho, Miguel Quintela-Fandino, Simon T Barry, Elza C de Bruin, Steve Colebrook, George Hawkins, Teresa Klinowska, Brijesh Maroj, Ganesh Moorthy, Peter G S Mortimer, Michele Moschetta, Myria Nikolaou, Liz Sainsbury, Geoffrey I Shapiro, Lillian L Siu, Aaron Richard Hansen
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Xiao X Wei, Lucia Kwak, Anis Hamid, Monica He, Christopher J Sweeney, Scott C Flanders, Matthew Harmon, Atish D Choudhury
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry. Prostate cancer and prostatic diseases 25 (2) (2022)
Edoardo Francini, Fang-Shu Ou, Justin Rhoades, Eric G Wolfe, Edward P O'Connor, Gavin Ha, Gregory Gydush, Kaitlin M Kelleher, Rupal S Bhatt, Steven P Balk, Christopher J Sweeney, Viktor A Adalsteinsson, Mary-Ellen Taplin, Atish D Choudhury
Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer. Cancers 13 (16) (2021)
Shahrzad Rafiei, Kenyon Fitzpatrick, David R Liu, Mu-Yan Cai, Haitham A Elmarakeby, Jihye Park, Cora Ricker, Bose S Kochupurakkal, Atish D Choudhury, William C Hahn, Steven P Balk, Justin H Hwang, Eliezer M Van Allen, Kent W Mouw
ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer. Cancer research 80 (11) (2020)
Heather A Parsons, Justin Rhoades, Sarah C Reed, Gregory Gydush, Priyanka Ram, Pedro Exman, Kan Xiong, Christopher C Lo, Tianyu Li, Mark Fleharty, Gregory J Kirkner, Denisse Rotem, Ofir Cohen, Fangyan Yu, Mariana Fitarelli-Kiehl, Ka Wai Leong, Melissa E Hughes, Shoshana M Rosenberg, Laura C Collins, Kathy D Miller, Brendan Blumenstiel, Lorenzo Trippa, Carrie Cibulskis, Donna S Neuberg, Matthew DeFelice, Samuel S Freeman, Niall J Lennon, Nikhil Wagle, Gavin Ha, Daniel G Stover, Atish D Choudhury, Gad A Getz, Eric P Winer, Matthew Meyerson, Nancy U Lin, Ian Krop, J Christopher Love, G Mike Makrigiorgos, Ann H Partridge, Erica L Mayer, Todd R Golub, Viktor A Adalsteinsson
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Abhishek Tripathi, Jeffrey G Supko, Kathryn P Gray, Zachary J Melnick, Meredith M Regan, Mary-Ellen Taplin, Atish D Choudhury, Mark M Pomerantz, Joaquim Bellmunt, Channing Yu, Zijie Sun, Sandy Srinivas, Philip W Kantoff, Christopher J Sweeney, Lauren C Harshman
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Rana R McKay, Hannah Mills, Lillian Werner, Atish D Choudhury, Toni K Choueiri, Susanna Jacobus, Amanda F Pace, Laura C Polacek, Mark M Pomerantz, Judith Prisby, Christopher J Sweeney, Meghara Walsh, Mary-Ellen Taplin
Evaluating a Video-Based, Personalized Webpage in Genitourinary Oncology Clinical Trials: A Phase 2 Randomized Trial. Journal of medical Internet research 21 (5) (2019)
Atish D Choudhury, Himisha Beltran
Retinoblastoma Loss in Cancer: Casting a Wider Net. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (14) (2019)
Atish D Choudhury, Kathryn P Gray, Jeffrey G Supko, Lauren C Harshman, Mary-Ellen Taplin, Amanda F Pace, Matthew Farina, Katherine A Zukotynski, Brandon Bernard, Philip W Kantoff, Mark Pomerantz, Christopher Sweeney
A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer. The Prostate (2018)